US2018036358A1PendingUtilityA1

Compositions and methods of treating viral infections

58
Assignee: LIFE SCIENCE NUTRITION ASPriority: Jan 28, 2009Filed: Oct 16, 2017Published: Feb 8, 2018
Est. expiryJan 28, 2029(~2.5 yrs left)· nominal 20-yr term from priority
Inventors:Jan Remmereit
A61P 43/00A61P 3/04A61P 17/00A61K 2300/00A23V 2200/30A23V 2200/332A61K 31/715A23L 33/40A23L 33/105A23V 2002/00A61K 36/87A61K 31/727A23V 2250/5438A61K 31/737A61K 31/7012A23V 2200/31A23V 2200/33A23V 2250/2116A23V 2250/51A61K 36/481A23L 29/256A61K 36/03A23V 2200/318A61K 31/352A61K 31/05
58
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to the field of nutraceuticals, and in particular to nutraceuticals comprising sulfated polysaccharides, Astragalus polysaccharides, resveratrol, and combinations thereof. These compositions find use in inducing physiological responses such, decreasing body fat, increasing lean body mass, alleviating the symptoms of colds, preventing the onset of colds, increasing energy, increasing the feeling of well-being in subjects, and improving skin tone and appearance.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method of inducing a physiological effect selected from the group consisting of alleviation of the symptoms of viral induced obesity, preventing viral induced obesity increasing lean body mass, decreasing body fat, increasing energy, increasing the feeling of well-being, alleviation of cold symptoms, and improving the skin tone, roughness and appearance in a subject comprising:
 providing a composition comprising effective amounts of a sulfated polysaccharide and a sialic acid,   and orally administering said composition to said patient under conditions such that said physiological effect is induced.   
     
     
         2 . The method of  claim 1 , wherein said symptom is obesity. 
     
     
         3 . The method of  claim 1 , wherein said administration of said composition induces weight reduction in a subject. 
     
     
         4 . The method of  claim 1 , wherein said administration of said composition increases the lean body mass of said subject. 
     
     
         5 . The method of  claim 1 , wherein said administration of said composition reduces cellulite in said subject. 
     
     
         6 . The method of  claim 1 , wherein said administration of said composition improves a skin parameter selected from the group consisting of improved skin tone, improved skin tightness in said subject and improved skin roughness. 
     
     
         7 . The method of  claim 1 , wherein said administration of said composition reduces body fat in said subject. 
     
     
         8 . The method of  claim 1 , wherein said composition is a dietary supplement. 
     
     
         9 . The method of  claim 1 , wherein said composition is a nutritional supplement. 
     
     
         10 . The method of  claim 1 , wherein said composition is provided in a food or a drink. 
     
     
         11 . The method of  claim 1 , wherein said sulfated polysaccharide is selected from the group consisting of fucan, chondroitin sulfate, heparin sulfate, dermatan sulfate, dextran sulfate, and keratin sulfate 
     
     
         12 . The method of  claim 11 , wherein said fucan is a fucoidan. 
     
     
         13 . The method of  claim 12 , wherein said fucoidan is marine brown algae. 
     
     
         14 . The method of  claim 12 , wherein said fucoidan is administered in a daily dosage of from 3 to 5 grams. 
     
     
         15 . The method of  claim 1 , wherein said sialic acid is selected from the group consisting of N-acetylneuraminic acid (NANA), n-glycolylneraminic acid (NGNA), and 2-keto-3-deoxynonic acid (KDN). 
     
     
         16 . The method of  claim 14 , wherein said sialic is administered in a daily dosage of from 0.1 g to 10.0 grams. 
     
     
         17 . A composition comprising an effective amount of a sulfated polysaccharide and a sialic acid. 
     
     
         18 . The composition of  claim 17 , wherein said composition is formulated for oral delivery. 
     
     
         19 . The composition of  claim 17 , wherein said composition is formulated for topical delivery.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.